Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Men have more severe COVID-19 outcomes than women.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.